现代免疫学

Established in 1981, Current Immunology, originally Shanghai Journal of Immunology, is the first journal in China specialized in immunology. The first Editor-in-Chief Dr. He Yu is a renowned immunologist and microbiologist graduated from Harvard University and the founding Director of Shanghai Institute of Immunology. Current Immunology is a peer-reviewed journal published bimonthly and co-sponsored by Shanghai Society for Immunology and Shanghai Institute of Immunology. The journal is also supervised by the Shanghai Municipal Education Commission. Up to now, Current Immunology has published more than 6 000 articles with overall downloads and citations of 730 995 and 29 555, respectively. The complex impact factor of the journal is 0.859 and the aggregate impact factor 0.747. Current Immunology is indexed by Chinese literature databases such as Chinese Science Citation Database (CSCD), A Guide to the Core Journals of China (Peking University Library), China Natural Science Core Journals, China Biomedicine Core Journals, and China Basic Medicine Core Journals. In addition, the overall hits of transnational articles and SCI percentage of third-party exhibiting websites in TrendMD database (a well-known international academic spreading tool) reach 2 410, with 72.34% from the United States and amounts to 70.94%, with the relevant science journal average of 50%, making Current Immunology influential to experts worldwide.

《现代免疫学》（原刊名《上海免疫学杂志》）创刊于1981年，是国内第一本免疫学专业期刊。本刊刊登了基础免疫学、临床免疫学、免疫学技术及其相关领域的最新研究成果，坚持报道国内外免疫学领域的新信息和新进展，并特邀在免疫学及相关领域造诣颇深的诸多知名学者为杂志的“专家述评”和“中青年学者论坛”栏目撰稿。 目前，《现代免疫学》期刊被中国科学引文数据库（CSCD）期刊、北大《中文核心期刊要目总览》、中国自然科学核心期刊、中国生物医学核心期刊、中国基础医学类核心期刊等著名数据库和权威检索系统收录，TrendMD（1款知名国际学术传播工具）跨国读者文章总点击数2410次，其中72.34%来自美国；而该款数据库中SCI期刊占总第三方展示网站数的70.94%，明显高于相关科技类杂志50%的平均水平，这都使《现代免疫学》在国内外专家同行间具有一定的知名度。